LARGE FAMILY FOR LARGE ACHIEVEMENTS
We develop modern prevention, diagnostics and therapy products for health preservation and improved quality of life.
Press centre
ANNUAL REGULAR ASSEMBLY /NOTICE
Notice of convening annual regular assembly of Bosnalijek d.d.
Pursuant to Article 233, paragraph (2), (3) and (4) of Company Law (Official Gazette of FB&H, No. 81/15) and Article 55, paragraph (2) and (3) of Statute of Bosnalijek D.D. (Consolidated text No: 2830/2017 of 18.09.2017), based on the Supervisory Board's Decision on Convening Annual Regular Assembly No: 1998/19 of 29 June 2019, we hereby announce:
MORE
PRESS CENTRE / NEWS
Bosnalijek Opens New Facility for Manufacturing Liquid and Semisolid Pharmaceutical Forms
With investment valued at 50 million convertible marks (BAM), Bosnalijek will see fivefold increase in its production capacities. This modern production plant ensures the reputation of a manufacturer with the highest quality standards.
In detail
PRESS CENTRE / NEWS
Two Bosnalijek Teams Won Valuable Prizes at Dolorex B2B Night Relay Race
Dolorex B2B night relay race, under a general sponsorship of Bosnalijek company, and Vienna Run4Lifestyle 10K Night Run, an international and socially responsible race, which opened the biggest festival of running in BiH “Olimpija Run Fest“, were held on Friday, 14 June 2019, in Sarajevo city center.
In detail
Useful Resources
decembar 07. 2019 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%